3AU0
 
 | | Structural and biochemical characterization of ClfB:ligand interactions | | Descriptor: | Clumping factor B, MAGNESIUM ION | | Authors: | Ganesh, V.K, Barbu, E.M, Deivanayagam, C.C.S, Le, B, Anderson, A.S, Matsuka, Y, Lin, S.L, Foster, T.F, Narayana, S.V.L, Hook, M. | | Deposit date: | 2011-01-28 | | Release date: | 2011-05-04 | | Last modified: | 2024-03-13 | | Method: | X-RAY DIFFRACTION (2.45 Å) | | Cite: | Structural and biochemical characterization of ClfB:ligand interactions
To be published
|
|
3ASW
 | |
3AT0
 | |
5JQ6
 | | Crystal structure of ClfA in complex with the Fab fragment of Tefibazumab | | Descriptor: | Clumping factor A, Tefibazumab FAB FRAGMENT HEAVY CHAIN, Tefibazumab FAB FRAGMENT LIGHT CHAIN | | Authors: | Ganesh, V.K. | | Deposit date: | 2016-05-04 | | Release date: | 2017-01-18 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (2.4 Å) | | Cite: | Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
EBioMedicine, 13, 2016
|
|
1AY6
 | | THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF | | Descriptor: | HIRUGEN, THROMBIN HEAVY CHAIN, THROMBIN LIGHT CHAIN, ... | | Authors: | Ganesh, V, Maryanoff, B.E, Tulinsky, A. | | Deposit date: | 1997-11-14 | | Release date: | 1998-03-18 | | Last modified: | 2023-08-02 | | Method: | X-RAY DIFFRACTION (1.8 Å) | | Cite: | Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif
Bioorg.Med.Chem.Lett., 6, 1996
|
|
2VR3
 | | Structural and Biochemical Characterization of Fibrinogen binding to ClfA from Staphylocccus aureus | | Descriptor: | CLUMPING FACTOR A, FIBRINOGEN GAMMA-CHAIN | | Authors: | Ganesh, V.K, Rivera, J.J, Smeds, E, Bowden, M.G, Wann, E.R, Gurusidappa, S, Fitzgerald, J.R, Hook, M. | | Deposit date: | 2008-03-25 | | Release date: | 2009-05-19 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | A Structural Model of the Staphylococcus Aureus Clfa-Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics.
Plos Pathog., 4, 2008
|
|
